These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17671180)

  • 1. Identification of Pax5 as a target of MTA1 in B-cell lymphomas.
    Balasenthil S; Gururaj AE; Talukder AH; Bagheri-Yarmand R; Arrington T; Haas BJ; Braisted JC; Kim I; Lee NH; Kumar R
    Cancer Res; 2007 Aug; 67(15):7132-8. PubMed ID: 17671180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastasis-associated protein 1 transgenic mice: a new model of spontaneous B-cell lymphomas.
    Bagheri-Yarmand R; Balasenthil S; Gururaj AE; Talukder AH; Wang YH; Lee JH; Kim YS; Zhang X; Jones DM; Medeiros LJ; Stephens LC; Liu YJ; Lee N; Kim I; Kumar R
    Cancer Res; 2007 Aug; 67(15):7062-7. PubMed ID: 17671172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple isoforms of PAX5 are expressed in both lymphomas and normal B-cells.
    Arseneau JR; Laflamme M; Lewis SM; Maïcas E; Ouellette RJ
    Br J Haematol; 2009 Nov; 147(3):328-38. PubMed ID: 19725825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oscillation between B-lymphoid and myeloid lineages in Myc-induced hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway.
    Yu D; Allman D; Goldschmidt MH; Atchison ML; Monroe JG; Thomas-Tikhonenko A
    Blood; 2003 Mar; 101(5):1950-5. PubMed ID: 12406913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling.
    Cozma D; Yu D; Hodawadekar S; Azvolinsky A; Grande S; Tobias JW; Metzgar MH; Paterson J; Erikson J; Marafioti T; Monroe JG; Atchison ML; Thomas-Tikhonenko A
    J Clin Invest; 2007 Sep; 117(9):2602-10. PubMed ID: 17717600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of the murine 1-cys peroxiredoxin gene by the B cell-specific activator protein, Pax5.
    Lee IS; Choi WH; Kim JY; Jeong JY; Kim MJ; Nam JH; Kim JH; Seo SB; Pak JH
    J Cell Biochem; 2008 May; 104(2):465-76. PubMed ID: 18172866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone acetyltransferase PCAF is involved in transactivation of Bcl-6 and Pax5 genes in immature B cells.
    Kikuchi H; Nakayama M; Kuribayashi F; Mimuro H; Imajoh-Ohmi S; Nishitoh H; Nakayama T
    Biochem Biophys Res Commun; 2015 Nov; 467(3):509-13. PubMed ID: 26456646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of sense and antisense promoter activity at the Csf1R locus in B cells by the transcription factor PAX5.
    Ingram RM; Valeaux S; Wilson N; Bouhlel MA; Clarke D; Krüger I; Kulu D; Suske G; Philipsen S; Tagoh H; Bonifer C
    Exp Hematol; 2011 Jul; 39(7):730-40.e1-2. PubMed ID: 21549805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-Lymphoma cells with epigenetic silencing of Pax5 trans-differentiate into macrophages, but not other hematopoietic lineages.
    Hodawadekar S; Yu D; Cozma D; Freedman B; Sunyer O; Atchison ML; Thomas-Tikhonenko A
    Exp Cell Res; 2007 Jan; 313(2):331-40. PubMed ID: 17098231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD19 is a major B cell receptor-independent activator of MYC-driven B-lymphomagenesis.
    Chung EY; Psathas JN; Yu D; Li Y; Weiss MJ; Thomas-Tikhonenko A
    J Clin Invest; 2012 Jun; 122(6):2257-66. PubMed ID: 22546857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
    Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
    J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Level of PAX5 in differential diagnosis of non-Hodgkin's lymphoma.
    Bharti B; Shukla S; Tripathi R; Mishra S; Kumar M; Pandey M; Mishra R
    Indian J Med Res; 2016 May; 143(Supplement):S23-S31. PubMed ID: 27748274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAX5 somatic mutation is rare in multiple myelomas and non-Hodgkin lymphomas of Korean patients.
    Je EM; Yoo NJ; Lee SH
    Hematol Oncol; 2014 Jun; 32(2):110-1. PubMed ID: 23737402
    [No Abstract]   [Full Text] [Related]  

  • 14. PAX5 is the transcriptional activator of mucolipin-2 (MCOLN2) gene.
    Valadez JA; Cuajungco MP
    Gene; 2015 Jan; 555(2):194-202. PubMed ID: 25445271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas.
    Malpeli G; Barbi S; Moore PS; Scardoni M; Chilosi M; Scarpa A; Menestrina F
    Haematologica; 2004 Sep; 89(9):1091-9. PubMed ID: 15377470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma.
    Sagaert X; de Paepe P; Libbrecht L; Vanhentenrijk V; Verhoef G; Thomas J; Wlodarska I; De Wolf-Peeters C
    J Clin Oncol; 2006 Jun; 24(16):2490-7. PubMed ID: 16636337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-grade B-Cell lymphomas with plasmacytic differentiation lack PAX5 gene rearrangements.
    George TI; Wrede JE; Bangs CD; Cherry AM; Warnke RA; Arber DA
    J Mol Diagn; 2005 Aug; 7(3):346-51. PubMed ID: 16049306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative genome-wide profiling of post-transplant lymphoproliferative disorders and diffuse large B-cell lymphomas.
    Rinaldi A; Kwee I; Poretti G; Mensah A; Pruneri G; Capello D; Rossi D; Zucca E; Ponzoni M; Catapano C; Tibiletti MG; Paulli M; Gaidano G; Bertoni F
    Br J Haematol; 2006 Jul; 134(1):27-36. PubMed ID: 16803564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of pax5 gene blocked by RNAi on biological characteristics of B cell malignant lymphoma].
    Yuan XL; Zhang B; Jiang LM; Shen LS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):799-803. PubMed ID: 18718064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells.
    Fazio G; Palmi C; Rolink A; Biondi A; Cazzaniga G
    Cancer Res; 2008 Jan; 68(1):181-9. PubMed ID: 18172310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.